Styrenix: The Plastic Company That Bought Thailand, Lost the Plot. Then Found Some Plastic.

Styrenix Performance Materials Q3 FY26 | EduInvesting
Q3 FY26 Results · 9M FY26 (Apr–Dec 2025)

Styrenix: The Plastic Company That Bought Thailand, Lost the Plot. Then Found Some Plastic.

₹16.3 crore consolidated profit on ₹871 crore revenue. A ₹1.9% margin. And an inventory write-down so brutal, even the board stopped pretending it was “strategy.” The story of how 75% of losses come from getting creative with brand transitions.

Market Cap₹3,441 Cr
CMP₹1,954
P/E Ratio20.2x
Div Yield2.76%
ROCE26.5%

They Make Plastic. Very Complicated Plastic. From Thailand Now.

  • 52-Week High / Low₹3,524 / ₹1,819
  • Q3 FY26 Revenue (Stand.)₹649 Cr
  • Q3 FY26 PAT (Stand.)₹44.3 Cr
  • Q3 EPS (Stand.)₹2.24
  • Annualised EPS (Q3×4)₹8.96
  • Book Value₹708
  • Price to Book2.76x
  • Dividend Yield2.76%
  • Debt / Equity0.26x
  • Promoter Hold46.2%
A Humble Admission: In Q3 FY26, Styrenix’s consolidated profit collapsed to ₹16.3 crore (1.9% margin). Down 62.5% YoY. You know why? Management bought a plastic factory in Thailand in January, built inventory under old brand names as part of a strategic “transition,” and now that inventory is worth 20–25% less than cost. The company calls this “economic consequence of price declines.” Investors call it a ₹100+ crore black hole that management helpfully diagnosed in their own concall as “more than 75% of the losses.” Transparency is refreshing, even when the news is terrible.

A Company That Makes Engineering Plastics, Now Also Makes Excuses

Meet Styrenix Performance Materials. Founded in 1973 as ABS Plastics Limited, it’s been through more ownership changes than a government property. First the global chemical multinationals. Then INEOS. Then, in 2022, a group called Shiva (yes, very Indian) bought 61% and rebranded the entire operation from “INEOS Styrolution India” to “Styrenix Performance Materials.” The message was simple: new management, fresh energy, let’s grow.

They make ABS resin (those hard plastic bits in your car dashboard), SAN copolymer (your refrigerator’s inner walls), and polystyrene (the foam that arrived with your online purchase and will outlive your grandchildren). These aren’t sexy products. They’re not AI. They’re not blockchain. But they’re in literally everything made of plastic in India, from your two-wheeler to your Samsung fridge to that terrible plastic pen you bought at a station.

Fast forward to 2025. The company has ₹3,441 crore market cap, 26.5% ROCE, and a very aggressive growth plan. They expanded to Thailand. They’re launching new brands (Styroloy, Asalac, HYSPEC). They’re pitching speciality grades as the future. It’s textbook PlayBook for Small-Cap Ambition.

Then Q3 happened. And suddenly everyone is using phrases like “inventory valuation impact” and “margin compression from product mix.” Translation: they bought plastic, prices fell, and now they’re sitting on a inventory loss the size of a small village.

Management’s Own Honesty (Feb 2026 Concall): “More than 75% of the consolidated delta/loss is associated with inventory (valuation impact).” They didn’t hide it. They didn’t sugar-coat it. They explained it in clinical detail, complete with percentage price declines of “20–25% on final products” and “as high as 30%” on raw materials. For a company that had previously been somewhat… aspirational… in its guidance, this was almost refreshing candour disguised as bad news.

They Buy Monomers, Turn Them Into Polymer Chains, Sell To OEMs. Margin Magic.

Engineering thermoplastics sound complicated because they are, but the business is straightforward: buy acrylonitrile, butadiene, and styrene (mostly imported); feed them into polymerization reactors at plants in Nandesari, Moxi, Katol, and Dahej; produce various grades of ABS, SAN, and polystyrene; sell to OEMs and converters.

Their market position in India: ABS = market leader. SAN = “more than 50%” merchant share. Polystyrene = growing but competitive. Their competitive edge rests on four pillars: (a) OEM relationships and approvals (18 months to qualify a new product in automotive); (b) customization and specialty grades; (c) distribution reach (four major plants, seven sales offices); (d) technical service and local presence (vs. imported substitutes).

The economics are formula-based. Management states “>70% of ABS business works on formula basis,” meaning price is tied to raw material cost + margin framework in contractual annual agreements. In inflationary times, they pass increases to customers. In deflationary times (like now), prices fall but at least it’s formulaic, not a price war in a WhatsApp group.

ABS India Share~51%Market Leader
SAN India Share>50%Merchant Market
Sales Volume 9M147.5 KT+7.4% YoY
New Facility Complication: January 2025, Styrenix acquired 100% of a Thai manufacturing plant (Ta Phut). 85 KTPA ABS, 100 KTPA SAN, 31 KTPA rubber capacity. The acquisition was debt-funded (~₹194 crore term loan). The plant operates at only 43% utilization currently. Why? Because they had to transition from INEOS brands (Novodur, Lustran) to Styrenix brands (Absolac, Absolan), and customer re-qualification takes 18 months in automotive. So they stockpiled inventory under the old brands while the approval process crawled forward. Then commodity prices fell 20–25%. Then the inventory became worth less than cost. Then Q3 became a nightmare.
💬 Drop a comment: Would you have done the same inventory build during a brand transition, or is that just value destruction in hindsight?

Q3 FY26: Standalone Holds Up. Consolidated? Not So Much.

Result type: Quarterly Results (Q3 FY26)  |  Q3 EPS (Standalone): ₹2.47  |  Annualised EPS (Q3×4): ₹9.88  |  Q3 Consolidated EPS: ₹0.83  |  9M EPS (Standalone): ₹7.61

Metric (₹ Cr) Q3 FY26
Dec 2025
Q3 FY25
Dec 2024
Q2 FY26
Sep 2025
YoY % QoQ %
Revenue (Standalone)649693603-6.3%+7.6%
Operating Profit767566+0.4%+14.7%
OPM %11.7%10.9%11%+80 bps+70 bps
PAT (Standalone)44.347.743-7.5%+3.0%
EPS ₹ (Standalone)2.242.422.18-7.4%+2.8%
The Standalone Trick: On a standalone (India-only) basis, Styrenix is actually performing reasonably — flat EBITDA YoY, slight margin improvement to 11.7%, volume growth of 7.6%. But when you consolidate Thailand (which it acquired mid-January 2025), the math crumbles: Q3 consolidated margin was only 5% EBITDA, ₹16.3 crore PAT (1.9% margin), and that’s because Thailand’s inventory losses and underutilization dragged the group down by more than 75% of the profit shortfall. Management isn’t hiding it. They’re explaining it. But that doesn’t make it better for shareholders holding the stock.
9M Context (April–December 2025): Standalone 9M revenue ₹1,988 crore (marginally lower YoY), EBITDA ₹243.6 crore (12.3% margin), PAT ₹150 crore (7.5% margin). That’s respectable. Consolidated 9M: revenue ₹2,619 crore, EBITDA ₹231.8 crore (8.8%), PAT ₹109.4 crore (4.2%). The acquisition’s drag is undeniable, but this is still early days post-acquisition.

Plastic Resin Multiples. What’s Fair When The Business Model Is Bifurcated?

Method 1: P/E Based (Standalone)

Standalone 9M FY26 EPS ≈ ₹7.61 (₹150 cr PAT ÷ 19.7 cr shares). Annualising: ~₹10.15. Specialty chemical peer median P/E ~25x (vs Styrenix’s current 20.2x). Fair P/E band: 18x–26x given ROCE of 26.5%.

Range: ₹1,827 – ₹2,639

Method 2: EV/EBITDA Based

FY25 EBITDA ₹352 crore (consolidated). Current EV ≈ ₹3,736 crore (from market data). EV/EBITDA ~10.6x. Specialty chemical peers trade 10x–14x. Current valuation is reasonable for a 26.5% ROCE business, but pending normalization of Thailand margins, a tighter range is prudent.

EV range (9x–13x on ~₹350 Cr normalized EBITDA): ₹3,150 Cr – ₹4,550 Cr → Per share:

Range: ₹1,598 – ₹2,306

Method 3: DCF Based

Standalone FY25 FCF ≈ ₹54 crore (conservative post-acquisition). Growth assumptions: 8–10% for 5 years (post-Thailand ramp). Terminal growth: 3.5%. WACC: 10.5%.

→ PV of 5-year FCFs at 10.5%: ~₹280 Cr
→ Terminal Value (3.5% growth / 7% cap rate): ~₹2,400 Cr
→ Total EV: ~₹2,680 Cr (net debt ≈ ₹250 Cr)

Range: ₹1,360 – ₹2,200

Fair Min: ₹1,600 CMP: ₹1,954 Fair Max: ₹2,400
⚠️ EduInvesting Fair Value Range: ₹1,600 – ₹2,400. CMP ₹1,954 sits slightly below midpoint. Valuation is reasonable for a company with 26.5% ROCE, but the Thailand ramp-up uncertainty and inventory risk in a deflationary environment warrant caution. This fair value range is for educational purposes only and is not investment advice. Please consult a SEBI-registered investment advisor before making any financial decision.

When A Small Indian Plastic Company Decides To Go APAC

Leave a Reply

error: Content is protected !!